Thought Leadership
Pfizer x Partner4Better Spotlight
TransPerfect supports the development of the Global Learning Program: Partner4Better, by delivering relevant educational content to a global audience in diverse languages....
LifeSci Talks COA Series | Exploring the Value Add of In-Study Interviews as a Critical COA Endpoint
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences sits down with Tom Willgoss, Patient-Centered Outcomes Research Chapter Lead, UK Site Head for Data Sciences at Roche to discuss the value of understanding and measuring...
Artificial Intelligence in Life Sciences – Latest Developments Presented by Industry Leaders
Join TransPerfect's discussion with industry-experts from Pfizer, Bayer, CodaMetrix, Biogen, BI, Novartis, and Syneos Health about how AI is accelerating changes in the life sciences industry and ways they are leveraging data to support their teams, studies, and products. ...
AI and MT for PV and Safety Office Hours - 6/12/24
Welcome to TransPerfect Life Sciences' AI and MT Ask an Expert Office Hours. In these sessions, we provide an opportunity for our community to submit their pressing questions for our experts to answer live, in the company of your industry peers. If you are looking for some...
Strategic Artificial Intelligence (AI) Implementation for Medical Device Companies
Medical device companies are leveraging artificial intelligence and machine learning to streamline regulated medical device content work streams, including labeling, marketing, and PMS reporting. Learn about implementing a strategic AI program and discover how top medical...
Meeting the MDR & IVDR Content Challenge: New AI and Automation Solutions for New Requirements
The European Union's introduction of the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) marks a significant shift towards enhanced transparency in the medical device sector. While these regulations are designed to strengthen patient safety...
Generative AI in Life Sciences Industry: Ethics, Applications, and Transformations
Discover the role of generative artificial intelligence (GenAI) in life sciences, including what is merely a trend vs. what is truly transformative. The speakers will explore pragmatic applications, ethical considerations and the potential future role of generative AI in life...
C3 Summit 2024 - London
Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to...
AI and MT for Regulatory and Clinical Content Office Hours - 5/15/24
Welcome to TransPerfect Life Sciences' AI and MT Ask an Expert Office Hours. In these sessions, we provide an opportunity for our community to submit their pressing questions for our experts to answer live, in the company of your industry peers. If you are looking for some...
Trial Interactive Customer Summit, OpTImize
Sheraton Commander Hotel 16 Garden St. Cambridge, MA 02138...
AI and MT "Ask an Expert" Office Hours - 4/10/2024
TransPerfect's experts gather to answer questions from global pharma, biotech, and medical device leaders regarding AI and MT use cases, challenges, opportunities, best practices, and more....
An Overview of Generative AI and Machine Translation for Life Sciences
Global life sciences companies are realizing the potential artificial intelligence (AI) and machine learning (ML) has to drive efficiency in content and translation management. To capitalize on this, organizations need to identify the right solutions. Discover important...
6 Pathways to Take Your MT Strategy to the Next Level in 2024
With 2024 well underway, innovators in the global life sciences and pharmaceutical industries continue to question how to maximize efficiencies and reduce complexities in clinical and regulatory content development and localization. As part of the broader technological roadmap,...
LifeSci Talks COA Series | Breaking the Hype Cycle: An Objective Look at Remote Research Strategies in DCTs
In the first part of TransPerfect's latest LifeSci Talks episode, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, with guest Dr. Michelle Longmire, CEO of Medable, spoke about how a Stanford doctor transitioned into a career of entrepreneurship, creating a...
LifeSci Talks COA Series | Exploring the Intersection of Clinical Practice and Entrepreneurship: Technological Innovation in Clinical Research
In this episode of TransPerfect LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Dr Michelle Longmire, CEO of Medable, to discuss her journey from clinical practice to entrepreneurship, driven by a passion for rare disease, and the...
Clinical Outcomes Assessments (COAs) in Clinical Trials: Copyright and Licensing
Navigating the intricate details of licensing and copyright agreements in COAs is a complex task, presenting possible challenges to multi-licensor coordination or in managing evolving study protocols. This complexity, however, is a necessity, serving as an essential tool to...
How to Approach the Protection of Personal Data and Commercially Confidential Information of EU Clinical Trial Applications: Practical Considerations
In this piece, we'll explore the two primary frameworks that are driving EU CTR transparency efforts: the European Medicines Agency’s Policy 70 and Regulation (EU) No. 536/2014 on clinical trials. Gain valuable insight into requirements, exceptions, and implications for all...
Localizing Platforms for Digital Health: The Importance of Post-Localization Context Review
In a landscape defined by continuous technological advancement, many organizations in the life sciences industry strive to increase audience engagement through digital modalities, such as mobile and web applications or web portals. Building a robust technological...
C3 Summit London 2024
THE BREWERY 52 Chiswell St London EC1Y 4SA United Kingdom...
Unlocking the Power of AI and Machine Learning in Life Sciences
Life sciences companies are putting artificial intelligence (AI) and machine learning (ML) into practice, realizing its potential to revolutionize adverse event detection, diagnostics, and more. For AI and ML to be truly effective, you need to give context to your data, teaching...